| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/27/2004 | US6682730 Transplants for myocardial scars |
| 01/27/2004 | CA2256247C New naphtalene compounds, their preparation and pharmaceutical compositions containing them |
| 01/27/2004 | CA2214720C Arylsulfonylamino hydroxamic acid derivatives |
| 01/25/2004 | CA2435526A1 Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 01/22/2004 | WO2004007711A1 Novel proteins and use thereof |
| 01/22/2004 | WO2004007655A1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid |
| 01/22/2004 | WO2004007654A1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 01/22/2004 | WO2004007522A2 Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 01/22/2004 | WO2004007519A1 Partial and full agonists of a1 adenosine receptors |
| 01/22/2004 | WO2004007517A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 01/22/2004 | WO2004007498A2 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 01/22/2004 | WO2004007494A1 Phenylalanine enamide derivatives |
| 01/22/2004 | WO2004007491A1 Azolidinone-vinyl fused-benzene derivatives |
| 01/22/2004 | WO2004007481A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 01/22/2004 | WO2004007480A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 01/22/2004 | WO2004007479A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 01/22/2004 | WO2004007478A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 01/22/2004 | WO2004007472A1 Ccr4 antagonist and medicinal use thereof |
| 01/22/2004 | WO2004007468A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/22/2004 | WO2004007464A1 Imidazole derivative |
| 01/22/2004 | WO2004007458A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 01/22/2004 | WO2004007457A2 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | WO2004007454A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 01/22/2004 | WO2004007453A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 01/22/2004 | WO2004007450A1 Novel indoline compound and medicinal use thereof |
| 01/22/2004 | WO2004007441A2 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same |
| 01/22/2004 | WO2004007439A1 Biaryl derivatives |
| 01/22/2004 | WO2004007437A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | WO2004007430A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 01/22/2004 | WO2004007423A1 Novel salt forms of poorly soluble probucol esters and ethers |
| 01/22/2004 | WO2004006938A1 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations |
| 01/22/2004 | WO2004006931A2 Pharmaceutical compostions comprising an allosteric carboxylic inhibitor of matrix metalloproteinase-13 and a selective inhibitor of cyclooxygenase-2 |
| 01/22/2004 | WO2004006930A1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 01/22/2004 | WO2004006925A1 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 01/22/2004 | WO2004006919A1 Medicinal composition for mitigating blood lipid or lowering blood homocystein |
| 01/22/2004 | WO2004006918A1 Phenylalanine enamide derivatives containing a spiro`3.5!non-1-ene ring for use as integrin inhibitors |
| 01/22/2004 | WO2004006915A1 Angiotensin non-at1 receptor stimulating agents for brain ischemia protection and for acute stroke treatment |
| 01/22/2004 | WO2004006905A1 Modafinil pharmaceutical compositions |
| 01/22/2004 | WO2004006899A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 01/22/2004 | WO2004006865A2 Compounds, compositions, and methods |
| 01/22/2004 | WO2004006853A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | WO2004006850A2 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 01/22/2004 | WO2004006847A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 01/22/2004 | WO2004006662A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARα GENE TRANSFERRED THEREINTO AND USE THEREOF |
| 01/22/2004 | WO2003097665A3 Mid 241 receptor, a novel g-protein coupled receptor |
| 01/22/2004 | WO2003082813A3 Improvements in pharmaceutical compositions |
| 01/22/2004 | WO2003080545A3 Substituted phenylacetic acids |
| 01/22/2004 | WO2003072030A3 Methods for preventing or treating cardiac arrhythmia |
| 01/22/2004 | WO2003066087A3 Kinases involved in the regulation of energy homeostasis |
| 01/22/2004 | WO2003064383A3 Phosphorus-containing compounds & uses thereof |
| 01/22/2004 | WO2003059911A3 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS |
| 01/22/2004 | WO2003055447A3 Heterocyclic acridone inhibitors of impdh enzyme |
| 01/22/2004 | WO2003048205A3 Novel proteins with il-6 inhibiting activity |
| 01/22/2004 | WO2003025121A3 Igf-binding protein-derived peptide or small molecule |
| 01/22/2004 | WO2003024395A8 Linked biaryl compounds |
| 01/22/2004 | WO2003024390A3 Hydroxyeicosenoic acid analogs |
| 01/22/2004 | WO2003008595A3 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 01/22/2004 | WO2002092622A8 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors |
| 01/22/2004 | WO2002078643A3 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | US20040015075 Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
| 01/22/2004 | US20040015068 Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow |
| 01/22/2004 | US20040014992 A dichlorobenzylcyanide or a dichlorophenylcyclohexyl acetic acid methyl ester; use as antagonist of serotonin receptor and dopamine, treating attention deficit hyperactivity disorder, Parkinson's disease, nervous system disorders |
| 01/22/2004 | US20040014973 Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines |
| 01/22/2004 | US20040014971 N-(4-(4-(2-oxo-1-phenyl-2-((2,2,2-trifluoroethyl)amino)ethyl)-1 -piperazinyl)-phenyl)-4'-(trifluoromethyl)-(1,1'-biphenyl)-2-carboxamide for treatment of obesity, diabetes, and cardiovascular disorders; decreases apoplioprotein secretion |
| 01/22/2004 | US20040014956 For increasing nuclease resistance of antisense sequences |
| 01/22/2004 | US20040014816 Novel aliphatic compounds, process for their preparation and their usage |
| 01/22/2004 | US20040014809 Novel n-( 2-phenyl-3-aminopropyl)naphtamides |
| 01/22/2004 | US20040014802 Aminoindazole derivatives and intermediates, preparation thereof, and pharmaceutical compositions thereof |
| 01/22/2004 | US20040014795 Calcium channel blockers; cardiovascular disorders; synergistic mixtures |
| 01/22/2004 | US20040014793 Stability in blood |
| 01/22/2004 | US20040014788 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht receptor agonists |
| 01/22/2004 | US20040014785 Cardiovascular disorders; antiischemic agents |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014782 Combination therapy for the treatment of diseases involving inflammatory components |
| 01/22/2004 | US20040014776 Anticancer agents; cyclin-dependent kinase inhibitor |
| 01/22/2004 | US20040014768 Psychological disorders; schizophrenia |
| 01/22/2004 | US20040014763 beta-sheet mimetics and composition and methods relating thereto |
| 01/22/2004 | US20040014760 4- (2-butylamino) -2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-YL) pyrazolo- [1,5-A] -1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/22/2004 | US20040014759 6,5-Fused bicyclic heterocycles |
| 01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 01/22/2004 | US20040014755 Rho-kinase inhibitors |
| 01/22/2004 | US20040014751 Antidiabetic agents |
| 01/22/2004 | US20040014748 Cardiovascular disorders, central nervous susyem disorders |
| 01/22/2004 | US20040014747 CRF receptor antagonists and methods relating thereto |
| 01/22/2004 | US20040014725 Adjust diffusion of oxygen; respiratory system disorders; cardiovascular disorders |
| 01/22/2004 | US20040014721 Method for using tethered bis(polyhydroxyphenyls) and O-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 01/22/2004 | US20040014706 Using protein antagonist; therapy for congestive heart failure; blocking gene expression |
| 01/22/2004 | US20040014693 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals |
| 01/22/2004 | US20040014686 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 01/22/2004 | US20040014685 Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/22/2004 | US20040014672 Novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 01/22/2004 | US20040014671 Cardiovascular disorders |
| 01/22/2004 | US20040014656 Method for diagnosing neuronal deseases and for treating primary hemostasis deficiency |
| 01/22/2004 | US20040014654 Cardiovascular disorders; anticholesterol agents; administering apolipoproteins and phospholipids mixture |
| 01/22/2004 | US20040014636 Pharmaceutical compositions comprising a modulator of adamts-1 |
| 01/22/2004 | US20040014590 Modulation pressure; efficient solvent extraction |
| 01/22/2004 | US20040014213 Selected cell delivery for heart failure |
| 01/22/2004 | US20040014208 Methods for culturing human lung mast cells and uses thereof |
| 01/22/2004 | US20040014188 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |